Roberto Valenza
Research Subjects
Research Interests
Roberto Valenza has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Alessio Ciminna
CdC Torina, Palermo, Italy, Italy
1 shared publication - Antonino Daidone
Radiation Oncology, CdC Villa Santa Teresa, Bagheria 90011, Palermo, Italy
1 shared publication - Daniela Sambataro
Medical Oncology, Department of Medicine and Surgery, Kore University of Enna, 94100 Enna, Italy
1 shared publication - Giuseppa Scandurra
Medical Oncology, Department of Medicine and Surgery, Kore University of Enna, 94100 Enna, Italy
1 shared publication - Ivan Fazio
Radiation Oncology Unit, CdC Macchiarella, Palermo 90100, Italy, Italy
1 shared publication - Maria Rosaria Valerio
University of Palermo, Italy, Italy
1 shared publication
Latest Publications
- Open Access
- 17 November 2025
- Published by MDPI AG in Preprints.org
Observational Study on the Effectiveness of L‐Arginine Plus Vitamin C in the Management of Cancer‐Related Fatigue
Background/Objectives: Cancer-related fatigue is one of the most distressing symptoms complained by neoplastic patients. L-arginine has a positive effect on physical performance in normal individuals, on fatigue in diseases other than cancer and on immune response in cancer patients. Methods: Forty-four cancer patients undergoing medical treatment were treated with oral l-arginine 1.66 g and 500 mg of vitamin C b.i.d. Cancer-related fatigue and health-related quality of life were recorded before treatment and after 15 and 30 days employing a visual analog scale and the European Organization for Research and Treatment of Cancer quality of life questionnaire (EORTC QLQ-C30) respectively. Results: Daily oral supplementation with l-arginine and vitamin C ameliorated cancer-related fatigue in a statistically significant manner. Health-related quality of life remained mostly unchanged despite patients had advanced cancer and were administered medical treatments including chemotherapy, immunotherapy and biologics. No effect on appetite preservation was observed but in a small percentage of patients Conclusions: Our exploratory study suggests a positive effect of oral supplementation with l-arginine plus vitamin C on cancer related fatigue without significant worsening of quality of life. Due to the heterogeneity of patients sample further studies are needed including more clinically homogenous groups of patients.
- 17 November 2025
- Published by MDPI AG in Preprints.org
Open AccessObservational Study on the Effectiveness of L‐Arginine Plus Vitamin C in the Management of Cancer‐Related Fatigue
Background/Objectives: Cancer-related fatigue is one of the most distressing symptoms complained by neoplastic patients. L-arginine has a positive effect on physical performance in normal individuals, on fatigue in diseases other than cancer and on immune response in cancer patients. Methods: Forty-four cancer patients undergoing medical treatment were treated with oral l-arginine 1.66 g and 500 mg of vitamin C b.i.d. Cancer-related fatigue and health-related quality of life were recorded before treatment and after 15 and 30 days employing a visual analog scale and the European Organization for Research and Treatment of Cancer quality of life questionnaire (EORTC QLQ-C30) respectively. Results: Daily oral supplementation with l-arginine and vitamin C ameliorated cancer-related fatigue in a statistically significant manner. Health-related quality of life remained mostly unchanged despite patients had advanced cancer and were administered medical treatments including chemotherapy, immunotherapy and biologics. No effect on appetite preservation was observed but in a small percentage of patients Conclusions: Our exploratory study suggests a positive effect of oral supplementation with l-arginine plus vitamin C on cancer related fatigue without significant worsening of quality of life. Due to the heterogeneity of patients sample further studies are needed including more clinically homogenous groups of patients.